Screener / SEC EDGAR /CIK 0001377121 /10-K filed Feb 25, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Protagonist Therapeutics, Inc PTGX

Compare with peers Embed
Planned sales, announced before they happen

2 trading plans running, 24 Form 144 notices for $93.1M

10-Q, 10-K and Form 144

What PTGX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Apr 22, 2024 to Sep 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Asif Ali
Chief Financial Officer
Adopted 10b5-1 plan Jun 30, 2026 10-Q Aug 5, 2026
What the company wrote
On June 30, 2026 , Asif Ali , our Chief Financial Officer , adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to (i) 73,214 shares of the Company’s common stock, (ii) 50% of the net shares issued to Mr. Ali after withholding taxes upon the vesting of restricted stock unit awards representing 21,346 shares of the Company’s common stock, and (iii) 50% of the net shares issued to Mr. Ali after withholding taxes upon the vesting of performance stock unit awards representing 12,800 shares of the Company’s common stock (assuming that such shares underlying performance stock units vest at target amounts) through September 30, 2027 , or such earlier date when all transactions under the trading plan are completed, subject to certain conditions.
William Waddill
member of our Board
Adopted 10b5-1 plan Feb 27, 2026 10-Q May 5, 2026
What the company wrote
On February 27, 2026, William Waddill, a member of our Board, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 27,000 shares of the Company’s common stock through May 31, 2027, or such earlier date when all transactions under the trading plan are completed, subject to certain conditions.
Dinesh V. Patel
Chief Executive Officer and a member of our Board of Directors
Adopted 10b5-1 plan Jan 30, 2026 10-Q May 5, 2026
What the company wrote
On January 30, 2026, Dinesh V. Patel, Ph.D., our Chief Executive Officer and a member of our Board of Directors (the “Board”), adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 300,000 shares of the Company’s common stock through October 9, 2026, or such earlier date when all transactions under the trading plan are completed, subject to certain conditions.
William D. Waddill
Board
Adopted 10b5-1 plan Dec 15, 2024 10-K Feb 21, 2025
What the company wrote
On December 15, 2024, William D. Waddill, a member of our Board, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 24,000 shares of the Company’s common stock through December 31, 2025, or such earlier date when all transactions under the trading plan are completed, subject to certain conditions.
Dinesh V. Patel
Chief Executive Officer and a member of our Board
Ended 10b5-1 plan Jul 15, 2024 10-Q Nov 7, 2024
What the company wrote
On July 15, 2024 , Dinesh V. Patel , our Chief Executive Officer and a member of our Board , terminated a trading plan intended to satisfy Rule 10b5-1(c) which he adopted on April 22, 2024 to sell up to 300,000 shares of the Company’s common stock through July 31, 2025, or such earlier date when all transactions under the trading plan were completed, subject to certain conditions. During the fiscal quarter ended September 30, 2024, no other director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case as defined in Item 408(a) of Regulation S-K). ​
Dinesh V. Patel
Chief Executive Officer and member of our Board
Adopted 10b5-1 plan Apr 22, 2024 10-Q Aug 6, 2024

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Sep 30, 2026 ASIF ALI
Officer
58,629 $8.3M
Aug 10, 2026 Dinesh Patel
CEO
225,000 $33.6M
Jun 23, 2026 WILLIAM WADDILL
Director
9,000 $1.0M
Jun 10, 2026 WILLIAM WADDILL
Director
9,000 $953K
May 29, 2026 WILLIAM WADDILL
Director
9,000 $904K
May 12, 2026 Dinesh Patel
CEO
75,000 $7.8M
May 8, 2026 BRYAN M & COURTNEY L GIRAUDO RT
Director
11,130 $1.1M
May 7, 2026 BRYAN GIRAUDO
Director
36,000 $3.6M
May 7, 2026 BRYAN M & COURTNEY L GIRAUDO RT
Director
12,000 $1.2M
Apr 21, 2026 Asif Ali
Officer
1,750 $185K
Mar 26, 2026 HAROLD SELICK
Director
24,000 $2.5M
Mar 26, 2026 ASIF ALI
Officer
24,765 $2.6M
Mar 26, 2026 ARTURO MOLINA
Officer
15,000 $1.6M
Mar 24, 2026 Dinesh Patel
CEO
54,700 $5.4M
Feb 17, 2026 LEWIS T WILLIAMS
Director
18,000 $1.5M
Feb 6, 2026 WILLIAM D WADDILL
Director
20,000 $1.7M
Jan 27, 2026 ASIF ALI
Officer
46,203 $3.8M
Jan 27, 2026 ARTURO MOLINA
Officer
5,000 $410K
Jan 26, 2026 ARTURO MOLINA
Officer
5,000 $411K
Jan 23, 2026 Dinesh Patel
CEO
108,273 $9.2M
Jan 23, 2026 ARTURO MOLINA
Officer
13,151 $1.1M
Jan 21, 2026 ARTURO MOLINA MD
Officer
9,514 $785K
Jan 21, 2026 DINESH V PATEL PH D
Officer, Director
34,438 $2.8M
Jan 21, 2026 Asif Ali
Officer
8,588 $708K
Show the other 16 notices

From the Form 144 XML filed with the SEC, since Jan 21, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PTGX/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.